Zurich Insurance Group Ltd FI Trims Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Zurich Insurance Group Ltd FI lowered its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 26.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 178,396 shares of the biotechnology company's stock after selling 65,156 shares during the quarter. Axon Enterprise makes up about 0.9% of Zurich Insurance Group Ltd FI's portfolio, making the stock its 23rd biggest position. Zurich Insurance Group Ltd FI owned approximately 0.23% of Axon Enterprise worth $106,024,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. New Wave Wealth Advisors LLC bought a new position in Axon Enterprise in the fourth quarter worth approximately $40,000. Y.D. More Investments Ltd bought a new position in Axon Enterprise in the fourth quarter worth approximately $45,000. Stonebridge Financial Group LLC bought a new position in Axon Enterprise in the fourth quarter worth approximately $53,000. GPS Wealth Strategies Group LLC grew its stake in Axon Enterprise by 74.1% in the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock worth $56,000 after purchasing an additional 40 shares in the last quarter. Finally, Berbice Capital Management LLC bought a new position in Axon Enterprise in the fourth quarter worth approximately $59,000. Institutional investors own 79.08% of the company's stock.

Analysts Set New Price Targets

Several research analysts recently issued reports on AXON shares. JMP Securities reissued an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Needham & Company LLC increased their target price on Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research report on Thursday, May 8th. Barclays increased their target price on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. Finally, The Goldman Sachs Group increased their target price on Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $652.73.

Insider Buying and Selling

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the transaction, the chief executive officer now owns 3,063,982 shares in the company, valued at approximately $1,657,583,622.18. This trade represents a 0.33% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Matthew R. Mcbrady sold 400 shares of Axon Enterprise stock in a transaction dated Wednesday, May 14th. The shares were sold at an average price of $718.40, for a total value of $287,360.00. Following the transaction, the director now owns 3,492 shares of the company's stock, valued at $2,508,652.80. The trade was a 10.28% decrease in their position. The disclosure for this sale can be found here. Insiders sold 23,764 shares of company stock worth $14,856,635 in the last 90 days. Insiders own 4.40% of the company's stock.

Axon Enterprise Stock Performance

Shares of AXON opened at $742.32 on Tuesday. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $742.34. The stock has a fifty day moving average price of $588.30 and a 200-day moving average price of $597.92. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The firm has a market cap of $57.79 billion, a PE ratio of 191.81, a P/E/G ratio of 5.17 and a beta of 1.24.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. The company had revenue of $603.63 million during the quarter, compared to analyst estimates of $585.67 million. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The firm's quarterly revenue was up 31.3% on a year-over-year basis. During the same quarter last year, the business posted $1.15 EPS. Equities research analysts predict that Axon Enterprise, Inc. will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.